New data suggests the omicron surge has peaked nationwide and cases are now starting to decline. But some areas of the country are still experiencing surges, and hospitals remain overwhelmed by a record number of patients—leading one physician to worry that the current wave will "break the [health care] system."
As cases of omicron and influenza surge across the United States this winter, Vox's Dylan Scott argues that "flurona" will become the new "post-pandemic normal" flu season. But Advisory Board's Christopher Kerns highlights how the future is uncertain and offers key guidance applicable in any situation.
Vaccinated people who previously recovered from Covid-19 had more protection against reinfection and hospitalization during the delta surge than those who were only vaccinated or were unvaccinated, according to a recent study from CDC. But the authors caution the findings cannot be applied to the omicron variant.
Writing for the Wall Street Journal, Emily Glazer and Chip Cutter explore three of the biggest challenges CEOs in the health care industry and beyond will face in 2022.
Writing for the Washington Post, Jon Gluck, the editorial director of special projects at Medium, explains how Covid-19 fatigue has led more people to eschew pandemic safety precautions—a move that puts the most vulnerable populations at risk.
Martin Shkreli, founder and former CEO of Vyera Pharmaceuticals, has been banned from the drug industry for life and ordered to repay $64.6 million in excess profits from Daraprim sales, in today's bite-sized hospital and health industry news from California, New York, and Massachusetts.
Print All Daily Briefing Article from
01/20/2022
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
